Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 4.9B | 4.8B | 4.7B | 4.5B |
Cost of revenue | 3.1B | 3.0B | 3B | 2.9B |
Gross profit | 1.8B | 1.8B | 1.7B | 1.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 731M | 806M | 365M | 672M |
Operating income | 395M | 320M | 269M | 350M |
Non operating interest income | ||||
Income | 6M | 6M | 8M | 262M |
Expense | 57M | 59M | 76M | 342M |
Other income expense | — | — | — | — |
Pretax income | 386M | 212M | 166M | 276M |
Tax provision | 104M | 57M | 52M | 52M |
Net income | 282M | 155M | 114M | 224M |
Basic EPS | — | 0.5 | — | 0.8 |
Diluted EPS | — | 0.5 | — | 0.8 |
Basic average shares | — | 286.4M | — | 289.3M |
Diluted average shares | — | 286.9M | — | 289.3M |
EBITDA | 595M | 471M | 458M | 751M |
Net income from continuing op. | 386M | 212M | 166M | 276M |
Minority interests | -6M | -5M | -4M | -7M |
Preferred stock dividends | 4M | 0 | 0 | 0 |